FURMENT
Commercial- Indications
- Pet gut health, Pet renal health, Pet liver health, Pet dermal health, Pet immune health
Company intelligence / Profile preview
Sirius Pet Biologics has launched 11 SKUs under the FURMENT brand targeting gut, immune, renal, and skin health in pets using proprietary postbiotic formulations. Products are distributed to both retail consumers and veterinary clinics across Singapore and Asia Pacific. No clinical trial data is published; efficacy is based on scientific rationale for microbiome modulation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sirius Pet Biologics.